Aegis capital corp. acted as sole bookrunner on a $12 million underwritten public offering for avenue therapeutics, inc. (nasdaq:atxi)

New york, ny / accesswire / october 12, 2022 / aegis capital corp. acted as sole bookrunner on a $12 million underwritten public offering for avenue therapeutics, inc. (nasdaq:atxi). about avenue therapeutics, inc. avenue therapeutics, inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting.
ATXI Ratings Summary
ATXI Quant Ranking